A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients

NCT04193527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinsonian Syndrome
Parkinson Disease(PD)
Multiple System Atrophy (MSA)
Progressive Supranuclear Palsy (PSP)
Essential Tremor

Interventions

DRUG: DaTSCAN™ Ioflupane (123I) Injection

Sponsor

GE Healthcare

Collaborators

[object Object]